About: BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes GLIX1, an oral, small molecule targeting DNA damage response in glioblastoma and other cancers; and APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.55 (-1.54%)
BLRXNASDAQBioLineRx Ltd
BioLineRx Ltd share price
BLRX price activity
Último preço
$ 2,550
Variação (24h)
-0,04 USD (-1,54%)
Volume
6.68K
Volume (média 4 sem.)
-
Abertura
$ 2,59
Variação do dia
$ 2,53 - $ 2,59
Fechamento anterior
$ 2,59
Último negócio
09 Sep, 8:00 pm GMT+0
Atrasado
09 Sep, 8:00 pm GMT+0
BLRX price performance
Atrasado
09 Sep, 8:00 pm GMT+0
quote.marketSignals